Effects of oral Akkermansia muciniphila supplementation in healthy dogs following antimicrobial administration

Maria C. Jugan, Adam J. Rudinsky, Alexander Gordon, Denise L. Kramer, Joshua B. Daniels, Oleg Paliy, Prosper Boyaka, Chen Gilor

Research output: Contribution to journalArticle

Abstract

OBJECTIVE To measure effects of oral Akkermansia muciniphila administration on systemic markers of gastrointestinal permeability and epithelial damage following antimicrobial administration in dogs. ANIMALS 8 healthy adult dogs. PROCEDURES Dogs were randomly assigned to receive either A muciniphila (109 cells/kg; n = 4) or vehicle (PBS solution; 4) for 6 days following metronidazole administration (12.5 mg/kg, PO, q 12 h for 7 d). After a 20-day washout period, the same dogs received the alternate treatment. After another washout period, experiments were repeated with amoxicillin-clavulanate (13.5 mg/kg, PO, q 12 h) instead of metronidazole. Fecal consistency was scored, a quantitative real-time PCR assay for A muciniphila in feces was performed, and plasma concentrations of cytokeratin-18, lipopolysaccharide, and glucagon-like peptides were measured by ELISA before (T0) and after (T1) antimicrobial administration and after administration of A muciniphila or vehicle (T2). RESULTS A muciniphila was detected in feces in 7 of 8 dogs after A muciniphila treatment at T2 (3/4 experiments) but not at T0 or T1. After metronidazole administration, mean change in plasma cytokeratin-18 concentration from T1 to T2 was significantly lower with vehicle than with A muciniphila treatment (–0.27 vs 2.4 ng/mL). Mean cytokeratin-18 concentration was lower at T1 than at T0 with amoxicillin-clavulanate. No other significant biomark-er concentration changes were detected. Probiotic administration was not associated with changes in fecal scores. No adverse effects were attributed to A muciniphila treatment. CONCLUSIONS AND CLINICAL RELEVANCE Detection of A muciniphila in feces suggested successful gastrointestinal transit following oral supplementation in dogs. Plasma cytokeratin-18 alterations suggested an effect on gastrointestinal epithelium. Further study is needed to investigate effects in dogs with naturally occurring gastrointestinal disease.

Original languageEnglish (US)
Pages (from-to)884-892
Number of pages9
JournalAmerican Journal of Veterinary Research
Volume79
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

mouth
Keratin-18
anti-infective agents
Dogs
dogs
metronidazole
Metronidazole
Feces
Clavulanic Acid
amoxicillin
feces
Amoxicillin
glucagon-like peptides
Glucagon-Like Peptides
Gastrointestinal Transit
gastrointestinal transit
Gastrointestinal Diseases
Probiotics
Therapeutics
digestive system diseases

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Effects of oral Akkermansia muciniphila supplementation in healthy dogs following antimicrobial administration. / Jugan, Maria C.; Rudinsky, Adam J.; Gordon, Alexander; Kramer, Denise L.; Daniels, Joshua B.; Paliy, Oleg; Boyaka, Prosper; Gilor, Chen.

In: American Journal of Veterinary Research, Vol. 79, No. 8, 01.08.2018, p. 884-892.

Research output: Contribution to journalArticle

Jugan, Maria C. ; Rudinsky, Adam J. ; Gordon, Alexander ; Kramer, Denise L. ; Daniels, Joshua B. ; Paliy, Oleg ; Boyaka, Prosper ; Gilor, Chen. / Effects of oral Akkermansia muciniphila supplementation in healthy dogs following antimicrobial administration. In: American Journal of Veterinary Research. 2018 ; Vol. 79, No. 8. pp. 884-892.
@article{ab3b79a0169a44a3add206818043d90c,
title = "Effects of oral Akkermansia muciniphila supplementation in healthy dogs following antimicrobial administration",
abstract = "OBJECTIVE To measure effects of oral Akkermansia muciniphila administration on systemic markers of gastrointestinal permeability and epithelial damage following antimicrobial administration in dogs. ANIMALS 8 healthy adult dogs. PROCEDURES Dogs were randomly assigned to receive either A muciniphila (109 cells/kg; n = 4) or vehicle (PBS solution; 4) for 6 days following metronidazole administration (12.5 mg/kg, PO, q 12 h for 7 d). After a 20-day washout period, the same dogs received the alternate treatment. After another washout period, experiments were repeated with amoxicillin-clavulanate (13.5 mg/kg, PO, q 12 h) instead of metronidazole. Fecal consistency was scored, a quantitative real-time PCR assay for A muciniphila in feces was performed, and plasma concentrations of cytokeratin-18, lipopolysaccharide, and glucagon-like peptides were measured by ELISA before (T0) and after (T1) antimicrobial administration and after administration of A muciniphila or vehicle (T2). RESULTS A muciniphila was detected in feces in 7 of 8 dogs after A muciniphila treatment at T2 (3/4 experiments) but not at T0 or T1. After metronidazole administration, mean change in plasma cytokeratin-18 concentration from T1 to T2 was significantly lower with vehicle than with A muciniphila treatment (–0.27 vs 2.4 ng/mL). Mean cytokeratin-18 concentration was lower at T1 than at T0 with amoxicillin-clavulanate. No other significant biomark-er concentration changes were detected. Probiotic administration was not associated with changes in fecal scores. No adverse effects were attributed to A muciniphila treatment. CONCLUSIONS AND CLINICAL RELEVANCE Detection of A muciniphila in feces suggested successful gastrointestinal transit following oral supplementation in dogs. Plasma cytokeratin-18 alterations suggested an effect on gastrointestinal epithelium. Further study is needed to investigate effects in dogs with naturally occurring gastrointestinal disease.",
author = "Jugan, {Maria C.} and Rudinsky, {Adam J.} and Alexander Gordon and Kramer, {Denise L.} and Daniels, {Joshua B.} and Oleg Paliy and Prosper Boyaka and Chen Gilor",
year = "2018",
month = "8",
day = "1",
doi = "10.2460/ajvr.79.8.884",
language = "English (US)",
volume = "79",
pages = "884--892",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "8",

}

TY - JOUR

T1 - Effects of oral Akkermansia muciniphila supplementation in healthy dogs following antimicrobial administration

AU - Jugan, Maria C.

AU - Rudinsky, Adam J.

AU - Gordon, Alexander

AU - Kramer, Denise L.

AU - Daniels, Joshua B.

AU - Paliy, Oleg

AU - Boyaka, Prosper

AU - Gilor, Chen

PY - 2018/8/1

Y1 - 2018/8/1

N2 - OBJECTIVE To measure effects of oral Akkermansia muciniphila administration on systemic markers of gastrointestinal permeability and epithelial damage following antimicrobial administration in dogs. ANIMALS 8 healthy adult dogs. PROCEDURES Dogs were randomly assigned to receive either A muciniphila (109 cells/kg; n = 4) or vehicle (PBS solution; 4) for 6 days following metronidazole administration (12.5 mg/kg, PO, q 12 h for 7 d). After a 20-day washout period, the same dogs received the alternate treatment. After another washout period, experiments were repeated with amoxicillin-clavulanate (13.5 mg/kg, PO, q 12 h) instead of metronidazole. Fecal consistency was scored, a quantitative real-time PCR assay for A muciniphila in feces was performed, and plasma concentrations of cytokeratin-18, lipopolysaccharide, and glucagon-like peptides were measured by ELISA before (T0) and after (T1) antimicrobial administration and after administration of A muciniphila or vehicle (T2). RESULTS A muciniphila was detected in feces in 7 of 8 dogs after A muciniphila treatment at T2 (3/4 experiments) but not at T0 or T1. After metronidazole administration, mean change in plasma cytokeratin-18 concentration from T1 to T2 was significantly lower with vehicle than with A muciniphila treatment (–0.27 vs 2.4 ng/mL). Mean cytokeratin-18 concentration was lower at T1 than at T0 with amoxicillin-clavulanate. No other significant biomark-er concentration changes were detected. Probiotic administration was not associated with changes in fecal scores. No adverse effects were attributed to A muciniphila treatment. CONCLUSIONS AND CLINICAL RELEVANCE Detection of A muciniphila in feces suggested successful gastrointestinal transit following oral supplementation in dogs. Plasma cytokeratin-18 alterations suggested an effect on gastrointestinal epithelium. Further study is needed to investigate effects in dogs with naturally occurring gastrointestinal disease.

AB - OBJECTIVE To measure effects of oral Akkermansia muciniphila administration on systemic markers of gastrointestinal permeability and epithelial damage following antimicrobial administration in dogs. ANIMALS 8 healthy adult dogs. PROCEDURES Dogs were randomly assigned to receive either A muciniphila (109 cells/kg; n = 4) or vehicle (PBS solution; 4) for 6 days following metronidazole administration (12.5 mg/kg, PO, q 12 h for 7 d). After a 20-day washout period, the same dogs received the alternate treatment. After another washout period, experiments were repeated with amoxicillin-clavulanate (13.5 mg/kg, PO, q 12 h) instead of metronidazole. Fecal consistency was scored, a quantitative real-time PCR assay for A muciniphila in feces was performed, and plasma concentrations of cytokeratin-18, lipopolysaccharide, and glucagon-like peptides were measured by ELISA before (T0) and after (T1) antimicrobial administration and after administration of A muciniphila or vehicle (T2). RESULTS A muciniphila was detected in feces in 7 of 8 dogs after A muciniphila treatment at T2 (3/4 experiments) but not at T0 or T1. After metronidazole administration, mean change in plasma cytokeratin-18 concentration from T1 to T2 was significantly lower with vehicle than with A muciniphila treatment (–0.27 vs 2.4 ng/mL). Mean cytokeratin-18 concentration was lower at T1 than at T0 with amoxicillin-clavulanate. No other significant biomark-er concentration changes were detected. Probiotic administration was not associated with changes in fecal scores. No adverse effects were attributed to A muciniphila treatment. CONCLUSIONS AND CLINICAL RELEVANCE Detection of A muciniphila in feces suggested successful gastrointestinal transit following oral supplementation in dogs. Plasma cytokeratin-18 alterations suggested an effect on gastrointestinal epithelium. Further study is needed to investigate effects in dogs with naturally occurring gastrointestinal disease.

UR - http://www.scopus.com/inward/record.url?scp=85051073921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051073921&partnerID=8YFLogxK

U2 - 10.2460/ajvr.79.8.884

DO - 10.2460/ajvr.79.8.884

M3 - Article

C2 - 30058857

AN - SCOPUS:85051073921

VL - 79

SP - 884

EP - 892

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 8

ER -